Neil Desai
Chairman at AADI BIOSCIENCE, INC.
Net worth: 3 M $ as of 30/04/2024
Network origin in Neil Desai first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
78
| Subsidiary | Biotechnology | 78 |
Abraxis BioScience, Inc. /Old/
 Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL
32
| Extinct | Pharmaceuticals: Major | 32 |
| Public Company | Biotechnology | 20 | |
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA.
12
| Extinct | Pharmaceuticals: Major | 12 |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA.
10
| Subsidiary | Biotechnology | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Neil Desai via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
APP Pharmaceuticals, Inc.
 APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Founder Director/Board Member President Chief Administrative Officer Sales & Marketing Public Communications Contact General Counsel Chief Operating Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal | |
Fresenius Kabi Pharmaceuticals Holding LLC
 Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member President General Counsel Corporate Officer/Principal Chief Operating Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| JUNO THERAPEUTICS INC | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Treasurer | |
NantWorks LLC
 NantWorks LLC Information Technology ServicesTechnology Services NantWorks LLC develops technology based semiconductor and advanced networks for healthcare improvements. Its solution is for life threatening diseases such as cancer, infectious diseases and Alzheimer’s. The company was founded by Patrick Soon-Shiong in September 2011 and is headquartered in Culver City, CA. | Information Technology Services | Chief Executive Officer General Counsel Corporate Officer/Principal Human Resources Officer | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| IMMUNOMEDICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
| NANTHEALTH, INC. | Packaged Software | Founder Director/Board Member Director/Board Member | |
| CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Director/Board Member | |
| Brown University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
| FATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman Director of Finance/CFO | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| RECEPTOS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Sales & Marketing | |
| University of California San Diego | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Abraxis Pharmaceutical Products
 Abraxis Pharmaceutical Products Medical SpecialtiesHealth Technology Abraxis Pharmaceutical Products provides injectible pharmaceutical products. It offers anti-infective, critical care, oncology and anesthetic/analgesic products. The company is located in Schaumburg, IL. | Medical Specialties | President President Chief Operating Officer | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chairman | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| PFIZER, INC. | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
CONNECT
 CONNECT Miscellaneous Commercial ServicesCommercial Services CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| The University of Chicago Booth School of Business | College/University | Corporate Officer/Principal Masters Business Admin | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Investor Relations Contact | |
Stalar 3, Inc.
 Stalar 3, Inc. Financial ConglomeratesFinance Stalar 3, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private company, foreign & domestic, seeking to become a public company. The firm has been engaged in initial financing and has commenced negotiations with operating entities. It was founded on November 13, 2007 and is headquartered in New York, NY. | Financial Conglomerates | President Director of Finance/CFO | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Bunge Ltd.
 Bunge Ltd. Agricultural Commodities/MillingProcess Industries Bunge Global SA operates as a holding company. engages in the supply and transportation of agricultural commodities. It operates through the following segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment is involved in the purchase, storage, transportation, processing, and sale of agricultural commodities and commodity products. The Refined and Specialty Oils segment engages in the processing, production, and marketing of products derived from vegetable oils. The Milling segment consists of the processing, production, and marketing of products derived primarily from wheat and corn. The Sugar and Bioenergy segment includes the manufacture and marketing of sugar and ethanol derived from sugarcane, as well as energy derived from the sugar and ethanol production process. The company was founded by Johann Peter Gottlieb Bunge in 1818 and is headquartered in St. Louis, MO. | Agricultural Commodities/Milling | Public Communications Contact Comptroller/Controller/Auditor | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal |
Statistics
International
| United States | 50 |
| Sweden | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 13 |
| Commercial Services | 4 |
| Technology Services | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 490 |
| Corporate Officer/Principal | 273 |
| Independent Dir/Board Member | 155 |
| Chairman | 133 |
| Undergraduate Degree | 78 |
Most connected contacts
| Insiders | |
|---|---|
| Patrick Soon-Shiong | 52 |
| Jerome Zeldis | 38 |
| Perry Karsen | 38 |
| Thomas Daniel | 35 |
| Rodman L. Drake | 33 |
| Michael Bonney | 32 |
| Sol Barer | 32 |
| Lonnie Moulder | 31 |
| Michael Friedman | 30 |
| Richard Maroun | 27 |
| Richard W. Barker | 26 |
| Jean Bizzari | 24 |
| William Rastetter | 24 |
| Walter L. Robb | 23 |
| Caley Castelein | 23 |
- Stock Market
- Insiders
- Neil Desai
- Company connections